UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5202

2023

Volltextzugriff (PDF)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II

Frontiers in pharmacology, 2023-07, Vol.14, p.1202287-1202287

2023

Volltextzugriff (PDF)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification

Frontiers in pharmacology, 2022-08, Vol.13, p.997618-997618

2022

Volltextzugriff (PDF)

Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021

Current medicinal chemistry, 2024-01, Vol.31 (33), p.5308-5350

2024

Volltextzugriff (PDF)

Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis

Antimicrobial agents and chemotherapy, 2021-04, Vol.95 (5)

2021

Volltextzugriff (PDF)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Nature communications, 2013-12, Vol.4 (1), Article 2907

2013

Volltextzugriff (PDF)

Therapeutic Inducers of Apoptosis in Ovarian Cancer

Cancers, 2019-11, Vol.11 (11), p.1786

2019

Volltextzugriff (PDF)

P2X purinergic receptor ligands: recently patented compounds

Expert opinion on therapeutic patents, 2010-05, Vol.20 (5), p.625-646

2010

Volltextzugriff (PDF)

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Journal of medicinal chemistry, 2013-05, Vol.56 (10), p.4093-4103

2013

Volltextzugriff (PDF)

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer

International journal of molecular sciences, 2019-04, Vol.20 (9), p.2112

2019

Volltextzugriff (PDF)

Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer

Molecular cancer therapeutics, 2014-02, Vol.13 (2), p.285-296

2014

Volltextzugriff (PDF)

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia

Molecules (Basel, Switzerland), 2021-02, Vol.26 (5), p.1212

2021

Volltextzugriff (PDF)

Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors

European journal of medicinal chemistry, 2017-12, Vol.141, p.101-112

2017

Volltextzugriff (PDF)

Characterization of Maleimide-Based Glycogen Synthase Kinase‑3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis

Journal of medicinal chemistry, 2013-06, Vol.56 (12), p.5115-5129

2013

Volltextzugriff (PDF)

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models

Translational oncology, 2017-08, Vol.10 (4), p.669-678

2017

Volltextzugriff (PDF)

Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis

Current molecular pharmacology, 2019-01, Vol.12 (1), p.27-49

2019

Volltextzugriff (PDF)

Molecular probes for P2X7 receptor studies

Current medicinal chemistry, 2007-06, Vol.14 (14), p.1505-1523

2007

Volltextzugriff (PDF)

Stereoselective synthesis towards unnatural proline based amino acids

ARKIVOC, 2016-02, Vol.2016 (3), p.134-144

2016

Volltextzugriff (PDF)

Efflux transporters and tight junction expression changes in human gastrointestinal cell lines cultured in defined medium vs serum supplemented medium

Life sciences (1973), 2018-08, Vol.207, p.138-144

2018

Volltextzugriff (PDF)

From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design

ACS medicinal chemistry letters, 2012-12, Vol.3 (12), p.1054-1058

2012

Volltextzugriff (PDF)

Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB

Australian journal of chemistry, 2021-05, Vol.74 (6), p.416-432

2021

Volltextzugriff (PDF)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Nature communications, 2013-12, Vol.4 (1), p.2907-2907

2013

Volltextzugriff (PDF)

Synthesis and evaluation of various heteroaromatic benzamides as analogues of –ylidene-benzamide cannabinoid type 2 receptor agonists

Tetrahedron letters, 2019-09, Vol.60 (36), p.151019, Article 151019

2019

Volltextzugriff (PDF)

Kinase targets in CNS drug discovery

Future medicinal chemistry, 2017-03, Vol.9 (3), p.303-314

2017

Volltextzugriff (PDF)

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis

Journal of medicinal chemistry, 2018-02, Vol.61 (3), p.791-803

2018

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(59)
Reviews
(1)

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(36)
Pharmacology & Pharmacy
(29)
Chemistry, Medicinal
(23)
Animals
(21)
Humans
(15)
Structure-Activity Relationship
(14)
Chemistry
(13)
Molecular Structure
(12)
Biochemistry & Molecular Biology
(11)
Mice
(11)
Physical Sciences
(11)
Dose-Response Relationship, Drug
(8)
Drug Design
(8)
Tuberculosis
(8)
Antitubercular Agents - Pharmacology
(7)
Chemistry, Multidisciplinary
(6)
Ligands
(6)
Mycobacterium Tuberculosis - Drug Effects
(6)
Brain Cancer
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification

Small Molecule Inhibitors of Human Papillomavirus: A Review of Research from 1997 to 2021

Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Therapeutic Inducers of Apoptosis in Ovarian Cancer

P2X purinergic receptor ligands: recently patented compounds

Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer

Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia

Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors

Characterization of Maleimide-Based Glycogen Synthase Kinase‑3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models

Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis

Molecular probes for P2X7 receptor studies

Stereoselective synthesis towards unnatural proline based amino acids

Efflux transporters and tight junction expression changes in human gastrointestinal cell lines cultured in defined medium vs serum supplemented medium

From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design

Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Synthesis and evaluation of various heteroaromatic benzamides as analogues of –ylidene-benzamide cannabinoid type 2 receptor agonists

Kinase targets in CNS drug discovery

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis

Suchergebnisse filtern